Samsara Insider Sold Shares Worth $6,022,436, According to a Recent SEC Filing-February 2024-www.financetom.com

Samsara Insider Sold Shares Worth $6,022,436, According to a Recent SEC Filing

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Samsara Insider Sold Shares Worth $6,022,436, According to a Recent SEC Filing

Sep 5, 2025 12:49 AM

03:38 AM EDT, 09/05/2025 (MT Newswires) -- John Bicket, 10% Owner, Director, Executive Vice President, Chief Technology Officer, on September 02, 2025, sold 170,000 shares in Samsara (IOT) for $6,022,436. Following the Form 4 filing with the SEC, Bicket has control over a total of 1,351,989 Class A common shares of the company, with 367,642 shares held directly and 984,347 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1642896/000141588925023754/xslF345X05/form4-09042025_110950.xml

Previous page： Terra Innovatum and GSR III Acquisition Corp. Remind Shareholders to Vote and Approve the Business Combination Prior to the October 7 Extraordinary General Meeting of Shareholders Next page： Barinthus Biotherapeutics to Combine with Clywedog Therapeutics to Target Metabolic and Autoimmune Diseases

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Terra Innovatum and GSR III Acquisition Corp. Remind Shareholders to Vote and Approve the Business Combination Prior to the October 7 Extraordinary General Meeting of Shareholders

Sep 30, 2025

GSRT shareholders are encouraged to use their voice and vote FOR the business combination and other proposals ahead of the deadline on October 6, 2025, at 11:59 p.m. ET Shareholders as of September 15, 2025, should vote their shares even if they no longer own them NEW YORK and AUSTIN, Texas, Sept. 30, 2025 (GLOBE NEWSWIRE) -- Terra Innovatum Srl...

Barinthus Biotherapeutics to Combine with Clywedog Therapeutics to Target Metabolic and Autoimmune Diseases

Sep 30, 2025

The combined company, Clywedog Therapeutics, will bring a portfolio that includes three differentiated, clinical stage product candidates which are being studied for the prevention/reversal of Type 1 and Type 2 Diabetes and the treatment of Celiac Disease. Four key value-driving milestones are expected within 18 months, including clinical proof of concept in multiple indications. Estimated cash runway for combined company...

Wysa Acquires Kins Physical Therapy to Close Gaps in U.S. Healthcare

Sep 30, 2025

AI company adopts health service to accelerate patient access to clinically proven AI BOSTON--(BUSINESS WIRE)-- Wysa today announced its acquisition of Kins, a U.S. physical therapy services company. The move addresses healthcare's notorious 17-year lag between clinically proven innovation and widespread adoption by taking a reverse approach: rather than waiting for healthcare services to adopt AI, Wysa is adopting...

Karbon Acquires Aider to Deliver the Future of AI-Powered Accounting and Bookkeeping

Sep 30, 2025

SAN FRANCISCO, Sept. 30, 2025 (GLOBE NEWSWIRE) -- Karbon, the global leader in practice management software for accounting, bookkeeping, tax and audit firms, today announced its acquisition of Aider, a pioneer in AI-powered advisory and reporting technology. The acquisition accelerates Karbon’s vision to transform the accounting profession through AI. Aider’s cutting-edge solution is already trusted by firms across the United...